Proteomic analysis of human substantia nigra identifies novel candidates involved in Parkinson's disease pathogenesis

Parkinson's disease (PD) pathology spreads throughout the brain following a region‐specific process predominantly affecting the substantia nigra (SN) pars compacta. SN exhibits a progressive loss of dopaminergic neurons responsible for the major cardinal motor symptoms, along with the occurrence of Lewy bodies in the surviving neurons. To gain new insights into the underlying pathogenic mechanisms in PD, we studied postmortem nigral tissues dissected from pathologically confirmed PD cases (n = 5) and neurologically intact controls (n = 8). Using a high‐throughput shotgun proteomic strategy, we simultaneously identified 1795 proteins with concomitant quantitative data. To date, this represents the most extensive catalog of nigral proteins. Of them, 204 proteins displayed significant expression level changes in PD patients versus controls. These were involved in novel or known pathogenic processes including mitochondrial dysfunction, oxidative stress, or cytoskeleton impairment. We further characterized four candidates that might be relevant to PD pathogenesis. We confirmed the differential expression of ferritin‐L and seipin by Western blot and demonstrated the neuronal localization of gamma glutamyl hydrolase and nebulette by immunohistochemistry. Our preliminary findings suggest a role for nebulette overexpression in PD neurodegeneration, through mechanisms that may involve cytoskeleton dynamics disruption. All MS data have been deposited in the ProteomeXchange with identifier PXD000427 (http://proteomecentral.proteomexchange.org/dataset/PXD000427).

[1]  Brad T. Sherman,et al.  DAVID: Database for Annotation, Visualization, and Integrated Discovery , 2003, Genome Biology.

[2]  Xiaodi A Deng,et al.  Ectopic expression of LIM-nebulette (LASP2) reveals roles in cell migration and spreading. , 2008, Cell motility and the cytoskeleton.

[3]  I. Ferrer,et al.  Assessing quantitative post‐mortem changes in the gray matter of the human frontal cortex proteome by 2‐D DIGE , 2008, Proteomics.

[4]  Matthias Mann,et al.  In-depth Analysis of the Adipocyte Proteome by Mass Spectrometry and Bioinformatics*S , 2007, Molecular & Cellular Proteomics.

[5]  C. T. Pappas,et al.  The Nebulin family: an actin support group. , 2011, Trends in cell biology.

[6]  Giulio Superti-Furga,et al.  Initial characterization of the human central proteome , 2011, BMC Systems Biology.

[7]  J. Potashkin,et al.  Limitations of Animal Models of Parkinson's Disease , 2010, Parkinson's disease.

[8]  Hwee Tong Tan,et al.  Quantitative and Temporal Proteome Analysis of Butyrate-treated Colorectal Cancer Cells*S , 2008, Molecular & Cellular Proteomics.

[9]  Bo Li,et al.  Zyxin Interacts with the SH3 Domains of the Cytoskeletal Proteins LIM-nebulette and Lasp-1* , 2004, Journal of Biological Chemistry.

[10]  D. Dickson,et al.  Evidence that incidental Lewy body disease is pre-symptomatic Parkinson’s disease , 2008, Acta Neuropathologica.

[11]  J. Cano,et al.  Blood–brain barrier disruption induces in vivo degeneration of nigral dopaminergic neurons , 2007, Journal of neurochemistry.

[12]  J. Stokes,et al.  Acquisition of iron bound to low molecular weight chelates by human monocyte-derived macrophages. , 1994, Journal of immunology.

[13]  R. Albin,et al.  Identification of proteins in human substantia nigra , 2008, Proteomics. Clinical applications.

[14]  P. Shannon,et al.  Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.

[15]  Johannes Griss,et al.  The Proteomics Identifications (PRIDE) database and associated tools: status in 2013 , 2012, Nucleic Acids Res..

[16]  T. Montine,et al.  Proteomic Identification of Novel Proteins in Cortical Lewy Bodies , 2007, Brain pathology.

[17]  J. Meldolesi,et al.  {alpha}-synuclein and its A30P mutant affect actin cytoskeletal structure and dynamics. , 2009, Molecular biology of the cell.

[18]  M. Beal,et al.  Parkinson's disease: a model dilemma , 2010, Nature.

[19]  Enikö Kövari,et al.  Proteomics in human Parkinson's disease research. , 2009, Journal of proteomics.

[20]  Brad T. Sherman,et al.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.

[21]  Martin Kuiper,et al.  BiNGO: a Cytoscape plugin to assess overrepresentation of Gene Ontology categories in Biological Networks , 2005, Bioinform..

[22]  D. Hochstrasser,et al.  Proteomic profiling of the substantia nigra demonstrates CNDP2 overexpression in Parkinson's disease. , 2012, Journal of proteomics.

[23]  P. Mulvihill,et al.  Filaments of Lewy bodies contain insoluble cytoskeletal elements. , 1992, The American journal of pathology.

[24]  Hitoshi Takahashi,et al.  The Lewy Body in Parkinson’s Disease and Related Neurodegenerative Disorders , 2012, Molecular Neurobiology.

[25]  D. Ito,et al.  Seipinopathy: a novel endoplasmic reticulum stress-associated disease. , 2009, Brain : a journal of neurology.

[26]  C. Wilson,et al.  Coupled oscillator model of the dopaminergic neuron of the substantia nigra. , 2000, Journal of neurophysiology.

[27]  Yan Wang,et al.  Mortalin: A Protein Associated With Progression of Parkinson Disease? , 2008, Journal of neuropathology and experimental neurology.

[28]  Carla Pasquarello,et al.  Combining low- and high-energy tandem mass spectra for optimized peptide quantification with isobaric tags. , 2010, Journal of proteomics.

[29]  Julian L Burton,et al.  Clinical, educational, and epidemiological value of autopsy , 2007, The Lancet.

[30]  B. Bergamasco,et al.  Proteome analysis of human substantia nigra in Parkinson's disease , 2004, Proteomics.

[31]  Yoav Ben-Shlomo,et al.  The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service. , 2002, Brain : a journal of neurology.

[32]  H. Groenewegen,et al.  The Proteome of the Locus Ceruleus in Parkinson's Disease: Relevance to Pathogenesis , 2012, Brain pathology.

[33]  D. Hochstrasser,et al.  Relative quantification of proteins in human cerebrospinal fluids by MS/MS using 6-plex isobaric tags. , 2008, Analytical chemistry.

[34]  E. Hirsch,et al.  Lack of up‐regulation of ferritin is associated with sustained iron regulatory protein‐1 binding activity in the substantia nigra of patients with Parkinson's disease , 2002, Journal of neurochemistry.

[35]  Yan Wang,et al.  Proteomic Identification of a Stress Protein, Mortalin/mthsp70/GRP75 , 2006, Molecular & Cellular Proteomics.

[36]  D. Butterfield,et al.  Proteomics in animal models of Alzheimer's and Parkinson's diseases , 2009, Ageing Research Reviews.

[37]  P. Burkhard,et al.  Neuroproteomics and Parkinson’s disease: don’t forget human samples , 2011, Expert review of proteomics.

[38]  M G Spillantini,et al.  Alpha-synuclein in Lewy bodies. , 1997, Nature.

[39]  C. Wiley,et al.  Brain Extracellular Matrix in Neurodegeneration , 2008, Brain pathology.

[40]  Cornelius J Werner,et al.  Proteome analysis of human substantia nigra in Parkinson's disease , 2008, Proteome Science.

[41]  Anushya Muruganujan,et al.  PANTHER version 7: improved phylogenetic trees, orthologs and collaboration with the Gene Ontology Consortium , 2009, Nucleic Acids Res..

[42]  C. McMurray,et al.  Neurodegeneration: diseases of the cytoskeleton? , 2000, Cell Death and Differentiation.

[43]  D. Sulzer,et al.  Multiple hit hypotheses for dopamine neuron loss in Parkinson's disease , 2007, Trends in Neurosciences.

[44]  Markus Müller,et al.  EasyProt--an easy-to-use graphical platform for proteomics data analysis. , 2013, Journal of proteomics.

[45]  Karl Mechtler,et al.  General statistical modeling of data from protein relative expression isobaric tags. , 2011, Journal of proteome research.